Mediar Therapeutics, Inc. — Form D
Mediar Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-06. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Other.
Offering
- Filed: 2019-02-06
- Form: D
- Accession: 0001766784-19-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 7
- Date of first sale: 2019-01-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-332291
Issuer
- Name: Mediar Therapeutics, Inc.
- CIK: 0001766784
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 OVERLAND STREET, BOSTON, MA, 02215
- Phone: 617-936-0960
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| David de Graaf | Director | Newton, MA |
| Brian Hubbard | Director | San Diego, CA |
| Stacey Brenner | Executive Officer | Cambridge, MA |
| Andreas Jurgeit | Director | Boston, MA |
| Bharat Srinivasa | Director | Boston, MA |
| Allan Marchington | Director | Boston, MA |
| Rahul Ballal | Director | Boston, MA |
| Rahul Ballal | Executive Officer | Boston, MA |
| Cassidy Blundell | Director | Boston, MA |
| Maina Bhaman | Director | Boston, MA |
| Adam Cotton | Director | Boston, MA |
| Simon Sturge | Director | Boston, MA |
| Marie-Claire Peakman | Director | Boston, MA |
| Meredith Fisher | Director | Half Moon Bay, CA |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |
| Michael Baran | Director | New York, NY |
| Anja Konig | Director | Boston, MA |
| Nandita Shangari | Director | Boston, MA |
| Peter Parker | Director | Boston, MA |
Other filings by this issuer (4)
More